-
Uncategorized1 week ago
Programmable control of bacterial operons with a single Cas13 RNA effector
Nature Biotechnology, Published online: 03 June 2026; doi:10.1038/s41587-026-03159-4 The SONAR system enables RNA-level control of bacterial operons using a single engineered Cas13 effector that can be...
-
Uncategorized1 week agoCross-Reactive T Cells Could Point to Broad Vaccines or Treatments for Measles, Nipah Virus
T cells are some of the immune system’s most important fighters. They can stop tumor growth and fight off severe infections. Scientists at La Jolla Institute...
-
Uncategorized1 week agoCelcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial
Gedatolisib could “establish a new standard of care” for PIK3CA-mutated breast cancer, an investigator said, but the results nonetheless appeared to disappoint investors.
-
Uncategorized1 week agoDisease Detection Gets Boost from Keck’s New Brain Reference Map
Investigators at the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine say they have created one of...
-
Uncategorized1 week agoEli Lilly issues data sharing ultimatum to 340B hospitals
Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. Hospitals, which have until Monday to comply, are urging the...
-
Uncategorized1 week agoSTAT+: Longevity startup NewLimit raises $435 million ahead of first clinical trial
Longevity startup NewLimit plans to launch its first clinical trial of a liver medicine after raising a staggering $435 million in new funding. NewLimit announced its...
-
Uncategorized1 week agoFulcrum exploring a potential sale after FDA sidelined its sickle cell drug
Fulcrum’s setback is the latest in a series of stumbles for the developers of sickle cell medicines, among them Pfizer, Novartis and Intellia Therapeutics. Read More
-
Uncategorized1 week agoSTAT+: Radiopharmaceutical shows promise in post-Pluvicto setting
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Today, we’re looking...
-
Uncategorized1 week ago
Kinase Droplets Activate Growth Signals, Path for Cancer Therapy
A new study published in Cell Reports titled, “Kinase condensates enrich ATP and trigger autophosphorylation,” suggests that cellular phase separation, a mechanism that organizes biomolecules into dense, liquid-like...
-
Uncategorized1 week ago
ASCO: Pfizer scores in lung, colorectal and prostate cancer but key readouts still to come
ASCO: Pfizer scores in lung, colorectal and prostate cancer but key readouts still to come
Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins
STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
